MedTrace Logo

A Single Group Study to Evaluate the Effects of a Supplement on Premenstrual Syndrome

NCT06124326 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-08-23

No results posted yet for this study

Summary

This is a virtual single-group study that will last three menstrual cycles (approximately 12 weeks). During the first menstrual cycle, participants will take the supplement as needed (pro re nata) when they feel symptoms of PMS, such as cramping or bloating. For the second and third menstrual cycles, Participants will take 2 capsules per day with water for 1 week, starting 4 days before their menstrual cycle and finishing on Day 3 of their cycle. Questionnaires will be completed at the following time points:

* Baseline
* Day 7 of their first cycle during the trial (After using the product PRN during their period)
* 4 days before their second period during the trial (After using the product PRN for the previous month)
* Day 3 of their second period during the trial (After using the product for 7 days straight)
* Day 3 of their third period of the trial (After using the product for 7 days straight)

Conditions

  • Premenstrual Syndrome

Interventions

DIETARY_SUPPLEMENT

Premenstrual Syndrome Supplement

Ginger, Curcumin, Organic Turmeric, Black Pepper, Magnesium, Zinc, Vitamin B6, Vitamin D.

Sponsors & Collaborators

  • Citruslabs

    collaborator INDUSTRY

  • Rael

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2024-01-20
Completion
2024-01-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06124326 on ClinicalTrials.gov